SCHEMBL6590361

SCHEMBL6590361

Cc1cc(C2CCN(S(=O)(=O)C(C)(C)C(=O)O)CC2)ccc1-c1cccc(OCC(O[SiH](c2ccccc2)c2ccccc2)C(C)(C)C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 12/20 0.60
MMP2 P08253 10/20 0.60
MMP1 P03956 2/20 0.59
MMP9 P14780 2/20 0.59
MMP14 P50281 2/20 0.59
PRMT5 O14744 2/20 0.34
WDR77 Q9BQA1 2/20 0.34
BCL9 O00512 2/20 0.33
CTNNB1 P35222 2/20 0.33
DHODH Q02127 1/20 0.33
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6585861 0.94 MMP3 (0.60) MMP3MMP2MMP1MMP9MMP14
SCHEMBL6590350 0.86 MMP3 (0.57) MMP3MMP2MMP1MMP9MMP14
SCHEMBL7538112 0.85 MMP2 (0.68) MMP3MMP2MMP1MMP9MMP14
SCHEMBL6436523 0.85 MMP2 (0.68) MMP3MMP2MMP1MMP9MMP14
SCHEMBL7408826 0.84 MMP2 (0.82) MMP3MMP2MMP1MMP9MMP14
SCHEMBL6587437 0.81 MMP2 (0.83) MMP3MMP2MMP1MMP9MMP14
SCHEMBL6433752 0.80 MMP2 (0.66) MMP3MMP2MMP1MMP9MMP14
SCHEMBL7432313 0.80 MMP2 (0.66) MMP3MMP2MMP1MMP9MMP14
SCHEMBL6585847 0.80 MMP3 (0.57) MMP3MMP2MMP1MMP9MMP14
SCHEMBL6590355 0.79 MMP2 (0.66) MMP3MMP2MMP1MMP9MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1036062-B1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS PFIZER LTD (GB) 2004-01-02 EP disclosed
US-6495568-B1 TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES WARNER-LAMBERT COMPANY 2002-12-17 US disclosed